Egg yolk antibody of type-2 duck adenovirus infection and preparation method

The invention provides an egg yolk antibody of type-2 duck adenovirus infection. An antigen used in a preparation process of the egg yolk antibody is a vaccine prepared by inactivated GD strain viruses. The type-2 duck adenovirus GD strain has been deposited in China Center for Type Culture Collecti...

Full description

Saved in:
Bibliographic Details
Main Authors WANG DANNA, LIN WENCHAO, WANG XIANGQIN, HU XIUXIANG, WANG XUEBO, LIU YANG, YAN RUIJUAN, WANG SAI, ZHANG HAIBO, LI CHAOYANG
Format Patent
LanguageChinese
English
Published 21.11.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides an egg yolk antibody of type-2 duck adenovirus infection. An antigen used in a preparation process of the egg yolk antibody is a vaccine prepared by inactivated GD strain viruses. The type-2 duck adenovirus GD strain has been deposited in China Center for Type Culture Collection in Wuhan University on June 5, 2016 with the accession number of CCTCC No: V201633. The egg yolk antibody of type-2 duck adenovirus infection is good in safety, and any local or systemic adverse reactions caused by the egg yolk antibody do not exist. By identification, safety test and analysis of potency test data, various indexes are stable and effectively; and the use effect of the egg yolk antibody is estimated by a method for injecting after counteracting toxic substances and a method for counteracting toxic substances after injecting. A result shows that the egg yolk antibody of type-2 duck adenovirus infection can effectively prevent and treat the type-2 duck adenovirus infection, and has good commercializ
Bibliography:Application Number: CN201710616312